Reliable disease models are essential for investigations on mechanisms and therapies. The Retinal organotypic culture can maintain the architecture and cellular connections within the tissue in vitro. The system is a refined retinal experiment platform. It narrows the gap between cell line studies and in vivo models and is flexible enough for sophisticated experimental procedures. It greatly reduces the consumption of time or resources. Retinas of many species in various development stages have been used for diverse explorations based on their morphologies and physical characteristics. But the culture time course and the viability of the cultured tissue restrict the utility of the system. Recently, researchers have made increasing attempts to improve the culture conditions and applications of this systems for retina experiments in vitro. Accordingly, there is a great need for a comprehensive summary of these systems for researchers seeking proper in vitro models. In this review, we clarify several key points for the culture procedure and summarize its utility in retinal research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tice.2018.01.005 | DOI Listing |
Acta Neuropathol Commun
November 2024
Donald K Johnson Eye Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Methods Mol Biol
September 2024
Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA, USA.
Neural Regen Res
March 2025
Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
JOURNAL/nrgr/04.03/01300535-202503000-00033/figure1/v/2024-06-17T092413Z/r/image-tiff The organotypic retinal explant culture has been established for more than a decade and offers a range of unique advantages compared with in vivo experiments and cell cultures. However, the lack of systematic and continuous comparison between in vivo retinal development and the organotypic retinal explant culture makes this model controversial in postnatal retinal development studies.
View Article and Find Full Text PDFPhytomedicine
July 2024
Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, Guangdong Province, PR China. Electronic address:
Background: Lycium barbarum glycopeptide (LbGp), extracted from the traditional Chinese medicine (TCM) of Lycium barbarum (LB), provides a neuroprotective effect against neurodegenerative and neuroimmune disorders contributing to its immunomodulatory and anti-inflammatory roles. Neuromyelitis optica spectrum disorders (NMOSD) is an autoimmune-mediated central nervous system (CNS) demyelinating disease, clinically manifested as transverse myelitis (TM) and optic neuritis. However, no drug has been demonstrated to be effective in relieving limb weakness and visual impairment of NMOSD patients.
View Article and Find Full Text PDFInt J Mol Sci
March 2024
Ophthalmology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, 22362 Lund, Sweden.
Inherited retinal degenerative diseases (IRDs) are a group of rare diseases that lead to a progressive loss of photoreceptor cells and, ultimately, blindness. The overactivation of cGMP-dependent protein kinase G (PKG), one of the key effectors of cGMP-signaling, was previously found to be involved in photoreceptor cell death and was studied in murine IRD models to elucidate the pathophysiology of retinal degeneration. However, PKG is a serine/threonine kinase (STK) with several hundred potential phosphorylation targets and, so far, little is known about the specificity of the target interaction and downstream effects of PKG activation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!